Laura Airas

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis

Merja Soilu‐Hänninen, Laura Airas, Ilkka Mononen et al. · Multiple Sclerosis Journal · 2005 · 235 citations

Nutrition, Neurological Disorder, Vitamin D Stores +16

CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis

Jeffrey H. Mills, Linda F. Thompson, Cynthia Mueller et al. · Proceedings of the National Academy of Sciences · 2008 · 216 citations · Full text

Immune Regulation, Immunology, Immunologic Mechanism +17

Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity

Heidi Högel, Eero Rissanen, Christian Barro et al. · Multiple Sclerosis Journal · 2018 · 163 citations

In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195

Eero Rissanen, Jouni Tuisku, Johanna Rokka et al. · Journal of Nuclear Medicine · 2014 · 161 citations · Full text